BIOTECHNICA INTERNATIONAL INC
DEF 14A, 1996-10-10
AGRICULTURAL PRODUCTION-CROPS
Previous: GULFSTREAM AEROSPACE CORP, 424B4, 1996-10-10
Next: EQUITEX INC, 4, 1996-10-10




                       SCHEDULE 14-A INFORMATION
                Proxy Statement Pursuant to Section 14(a)
                 of the Securities Exchange Act of 1934


Filed by the Registrant				



Check the appropriate box:
    Preliminary Proxy Statement
X   Definitive Proxy Statement
    Definitive Additional Materials
    Soliciting Material Pursuant to 240.14a-11(c) or 240.14a-12





                       BioTechnica International, Inc.
                 (Name of Registrant as Specified in Its Charter)


Payment of Filing Fee (Check the appropriate box)

X  $125 per Exchange Act Rules 0-11(c)(1)(ii), 14a-6(i)(1),
    or 14a-6(j)(2).
   $500 per each party to the controversy pursuant to Exchange Act Rule 
   14a-6(i)(3).
   Fee computed on table below per Exchange Act Rules 14a-6(i)(4)
   and 0-11.

     1.    Title of each class of securities to which transaction 
           applies:
     __________________________________________________________________

     2.    Aggregate number of securities to which transaction applies
     __________________________________________________________________
	
     3.    Per unit price or other underlying value of transaction 
           computed pursuant to Exchange Act Rule 0-11:
	__________________________________________________________________

     4.    Proposed maximum aggregate value of transaction:
	__________________________________________________________________

_    Check box if any part of the fee is offset as provided by Exchange  
     Act Rule 0-11(a)(2) and identify the filing for which the offsetting 
     fee was paid previously.  Identify the previous filing by 
     registration statement number, or the Form or Schedule and the date 
     of its filing.

     1.    Amount Previously Paid:
		__________________________________________________________________

     2.    Form, Schedule or Registration Statement No.:
	__________________________________________________________________

     3.    Filing Party:
	__________________________________________________________________

     4.    Date Filed:
	

                       BIOTECHNICA INTERNATIONAL, INC.
                         4001 War Memorial Drive
                            Peoria, IL  61614 
                              (309) 681-0300

                  NOTICE OF ANNUAL MEETING OF SHAREHOLDERS
                      To be held on November 12, 1996

To the Shareholders:

   NOTICE IS HEREBY GIVEN that the annual meeting of shareholders (the 
"Annual Meeting") of BioTechnica International, Inc., a Delaware 
corporation (the "Corporation" or "BioTechnica"), will be held at the 
Signature Inn, 4112 North Brandywine Drive, Peoria, Illinois 61614, on 
Tuesday, November 12, 1996 at 10:00 A.M., local time, for the following 
purposes:

   (1) To elect seven directors to serve until the next annual meeting 
and until their successors shall be elected and shall qualify;

   (2) To ratify the appointment of KPMG Peat Marwick LLP, as independent 
auditors of the Corporation for the fiscal year ending June 30, 1997; and

   (3) To transact such other business as may properly come before the 
Annual Meeting or any adjournment thereof.

 	All of the above matters are more fully described in the 
accompanying Proxy Statement, into which this Notice is incorporated by 
reference. 

 	The Board of Directors has fixed the close of business on September 
20, 1996 as the record date for the determination of shareholders 
entitled to notice of and to vote at the Annual Meeting or any 
adjournment thereof, and only shareholders of record at the close of 
business on that date will be entitled to vote.

 	IN ORDER THAT YOUR SHARES BE REPRESENTED AT THE ANNUAL MEETING, 
PLEASE FILL OUT, DATE, SIGN AND RETURN THE ENCLOSED PROXY PROMPTLY OR 
PLAN TO ATTEND THE ANNUAL MEETING IN PERSON OR BY PROXY.  A RETURN 
ADDRESSED ENVELOPE, WHICH REQUIRES NO POSTAGE, IS ENCLOSED.  IF YOU LATER 
DESIRE TO REVOKE OR CHANGE YOUR PROXY FOR ANY REASON, YOU MAY DO SO AT 
ANY TIME BEFORE THE VOTING, BY DELIVERING TO THE CORPORATION A WRITTEN 
NOTICE OF REVOCATION OR A DULY EXECUTED PROXY BEARING A LATER DATE OR BY 
ATTENDING THE ANNUAL MEETING AND VOTING IN PERSON.

                               By Order of the Board of Directors


                      								 Bruno Carette
                               President and Chief Operating Officer
Peoria, Illinois
October 10, 1996











                      BIOTECHNICA INTERNATIONAL, INC.
                         4001 War Memorial Drive
                            Peoria, IL  61614

                             PROXY STATEMENT
   
                     ANNUAL MEETING OF SHAREHOLDERS
 
                     To be held on November 12, 1996

                           GENERAL INFORMATION

   INTRODUCTION.  This Proxy Statement is furnished in connection with 
the solicitation by and on behalf of the Board of Directors of the 
Corporation of proxies for use at the annual meeting of shareholders to 
be held at the Signature Inn, 4112 North Brandywine Drive, Peoria, 
Illinois 61614, on Tuesday, November 12, 1996, at 10:00 A.M., local time, 
and at any adjournment thereof ("Annual Meeting"), and, together with the 
enclosed Form of Proxy and Annual Report to Shareholders for the fiscal 
year ended June 30, 1996 (the "Annual Report"), is being mailed to the 
shareholders on or about October 10, 1996.  Except for items specifically 
incorporated by reference herein, the Annual Report does not form any 
part of this Proxy Statement.  The complete mailing address of the 
Corporation's principal executive offices is 4001 War Memorial Drive, 
Peoria, Illinois 61614.

   REVOCABILITY OF PROXIES.  Any proxy given pursuant to this 
solicitation may be revoked by the person giving it at any time before 
the voting by delivering to the Corporation a written notice of 
revocation or a duly executed proxy bearing a later date or by attending 
the meeting and voting in person.

   COST OF SOLICITATION.  The entire cost of this solicitation will be 
paid by the Corporation.  In addition, the Corporation may reimburse 
brokerage firms and other persons representing beneficial owners of 
shares for their expenses in forwarding solicitation material to such 
beneficial owners.  In addition to solicitation by mail, officers and 
regular employees of the Corporation may solicit proxies from 
shareholders by telephone, telegram or personal interview.  Such persons 
will receive no additional compensation for such services.

   QUORUM AND VOTING.  The authorized capital stock of the Corporation 
consists of 150,000,000 shares of common stock, $.01 par value; 
11,100,000 shares of Class A common stock, $.01 par value; 11,100,000 
shares of Class B common stock, $.01 par value; and 2,000,000 shares of 
Preferred Stock, $.01 par value (collectively, the shares of the common 
stock, Class A common stock, Class B common stock, and Preferred Stock 
may be referred to herein as the "Capital Stock").  As of September 20, 
1996, there are outstanding 115,379,628 shares of common stock;
- -0- shares of Class A common stock, -0- shares of Class B common stock; 
and 900,000 shares of Class A Preferred Stock.  All of the issued and 
outstanding shares of common stock of record as of September 20, 1996 are 
entitled to vote at the Annual Meeting.  

   Only shareholders of record (not including Treasury Shares) of the 
115,379,628 shares of the common stock, outstanding as of the close of 
business on September 20, 1996, will be entitled to vote.  Each share of 
common stock is entitled to one vote upon each matter submitted to a vote 
of the shareholders of the Corporation at the Annual Meeting or any 
adjournment thereof.  The presence, in person or by proxy, of the holders 
of a majority of the outstanding shares of the common stock entitled to 
vote is necessary to constitute a quorum at the Annual Meeting.  Votes 
submitted as abstentions on any matter to be voted on at the Annual 
Meeting will be counted as votes against such matters.  Broker non-votes 
will not count for or against the election of directors, or the 
ratification of the appointment of KPMG Peat Marwick LLP as the 
independent auditors of the Corporation.


            PROPOSAL 1:  ELECTION OF DIRECTORS

   In accordance with the Corporation's Bylaws, the Board of Directors 
has fixed the number of directors at seven (7).  At the Annual Meeting, 
the shareholders of the Corporation will be asked to consider and vote 
upon the election of seven (7) directors to serve until the next annual 
meeting and until their successors shall be elected and shall qualify.  
Unless authority to vote for any of the nominees named below is withheld, 
the shares represented by the enclosed proxy will be voted for the 
election of such nominees as directors of the Corporation.  The Board of 
Directors has no reason to believe that any nominee will become 
unavailable for election.  However, in the event any one or more of such 
nominees shall unexpectedly become unavailable for election, the shares 
represented by the enclosed proxy will be voted for the election of such 
other persons as may be designated by the Board of Directors.

   Pursuant to the terms of the Credit Enhancement and Reorganization 
Agreement dated October 26, 1993, by and among Groupe Limagrain Holding, 
S.A. ("Limagrain"), Limagrain Genetics Corp. ("LG Corp.") and the 
Corporation (the "Limagrain Agreement"), approved by the shareholders at 
the March 7, 1994 Annual Meeting of Shareholders, LG Corp. agreed to 
cause no less than two (2) of the members serving on the Board of 
Directors at the time the Corporation entered into the Limagrain 
Agreement (the "Continuing Directors") to sit on the Board of Directors 
of the Corporation at all times during the three (3) year period 
following the Second Closing (as such term is defined in the Limagrain 
Agreement) which occurred on March 7, 1994.  Dr. Hardy and Mr. Hittinger 
have been named as the Continuing Director nominees for election at the 
Annual Meeting.

   The following information is furnished with respect to the nominees 
for election as Directors of the Corporation:

                            Principal Occupations the Last       Director
Name               Age      Five Years; Other Directorships        Since  

George R. Allbritten 65   Mr. Allbritten retired as the Vice        1994        
                          President-Finance, Secretary, Treasurer,
                          and Chief Financial Officer of the 
                          Corporation on August 31, 1994, an office
                          he had held since October 1993.  From
                          December 1990 to October 1993, Mr.
                          Allbritten was President-Chief Operating
                          Officer of Ferry-Morse Seed Company, a
                          subsidiary of Limagrain, where he also
                          served as Senior Vice President from 1983
                          to 1990 and Vice President-Finance from
                          1973 to 1983.


Ralph W.F. Hardy      62  In 1996, Dr. Hardy became President of    1984 
                          the National Agricultural Biotechnology
                          Council and a Board member and Corporate
                          Secretary of United States Department of
                          Agriculture's Alternative Agriculture 
                          Research and Commercialization Corpora-
                          tion.  From September 1987 until August
                          1995, Dr. Hardy was President and Chief
                          Executive Officer of the Boyce Thompson
                          Institute for Plant Research at Cornell
                          University. From November 1984 to January
                          1986, Dr. Hardy was President and Chief
                          Operating Officer of the Corporation.

William C. Hittinger  73  Mr. Hittinger retired as Executive Vice   1992
                          President of RCA Corporation in 1986, 
                          after being with the company since 1970.
                          Mr. Hittinger served on the RCA Board of
                          Directors from 1974 to 1982.  Prior to
                          joining RCA, Mr. Hittinger was President 
                          of General Instrument Corporation, a post
                          he held from 1968.  He is a fellow of the
                          Institute of Electrical and Electronics
                          Engineers (IEEE); a trustee of Lehigh
                          University; and a member of the National
                          Academy of Engineers.

Claude Agier         51   Mr. Agier has been a member of the   
                          Limagrain Cooperative since 1966 and      1994
                          has served as a director of all the
                          companies belonging to the Field
                          Seeds Division of the Limagrain Group
                          since 1985.  Mr. Agier manages a farm
                          of 150 acres.

Jean Ferrand         64   Mr. Ferrand has served as Chairman of     1994
                          the Board of Directors since March 1994.
                          Mr. Ferrand is a farmer and rancher by
                          profession.  He has been a member of the
                          Limagrain Cooperative Board of Directors
                          since 1966 and Deputy Chairman since 1984.
                          He is Chairman of the Board of Directors
                          of all the companies belonging to the 
                          Field Seeds Division of the Limagrain 
                          Group.  Mr. Ferrand serves as a director
                          of the agricultural Cooperative COPAVAL,
                          and the Wheat Producers Association (Paris).  
                          He is a Regional Legal Arbitrator, and
                          member of the City Council of St. 
                          Pourcain sur Sioule (Allier, France).

Laurent Petoton      60   Mr. Petoton has been a member of the      1994
                          Limagrain Cooperative since 1971 and
                          has served as director since 1978.  He
                          has been Chairman of the Board of
                          Directors of Force Limagrain BV (Holland)
                          since 1989 and has served as a director
                          of all the companies belonging to the
                          Field Seeds Division of the Limagrain
                          Group since 1985.  Mr. Petoton is a 
                          Board member of the local branch of the  
                          Credit Agricole Bank.

Emmanuel Rougier     44   Chief Executive Officer ("CEO") of the    1994
                          Corporation since March 1994, Mr. 
                          Rougier has been a member of the 
                          Limagrain Group Operating Committee
                          since 1989.  He has served as a
                          director and Chief Executive Officer
                          of the principal companies of the
                          Field Seeds Division of the Limagrain
                          Group since 1989.  Mr. Rougier is Vice
                          President of SEPROMA (French Hybrid
                          Corn Seed Companies Organization) and
                          Vice President of FFSF (French Forage
                          and Lawn Grass Seed Companies
                          Association).  He was nominated Export
                          Trade Advisor of the French Ministry of
                          Export and Trade in 1993.


DIRECTOR'S COMPENSATION, MEETINGS AND COMMITTEES

  Directors who are not salaried employees of, or consultants to, the 
Corporation or representatives of Limagrain are entitled to receive an 
annual retainer of $4,000 each.  Directors who are salaried employees of 
the Corporation are not entitled to any additional remuneration above and 
beyond their salary.  Directors who are representatives of Limagrain are 
not entitled to any remuneration from the Corporation.  Directors who are 
consultants to the Corporation are not entitled to any additional 
remuneration above and beyond the amounts set forth in their individual 
consulting agreements.  During the fiscal year ended June 30, 1996 
("Fiscal 1996"), Messrs. Ferrand, Rougier, Agier and Petoton were 
representatives of Limagrain, and therefore, received no remuneration 
from the Company for their services as Directors of the Corporation.  Dr. 
Hardy and Mr. Hittinger have consulting agreements with the Corporation 
which provide for the payments of $15,000 per year.  During Fiscal 1996, 
Dr. Hardy and Mr. Hittinger were each paid $15,000.  Mr. Allbritten 
receives an annual retainer of $4,000.

   The Board of Directors of the Corporation held two (2) meetings during 
Fiscal 1996.  During that fiscal year, no incumbent director attended 
fewer than 100% of the meetings of the Board of Directors and the 
committees of the Board of Directors upon which he served.

   The Board of Directors has appointed an Audit Committee and a 
Compensation Committee. The Audit Committee consists of Dr. Hardy, Mr. 
Hittinger, and Mr. Rougier.  The Audit Committee's functions are to 
recommend the selection of independent auditors and to carry out such 
activities related to the financial statements of the Corporation as the 
Board of Directors shall from time to time request.  The Audit Committee 
held one (1) meeting during Fiscal 1996.

   The Compensation Committee, which consists of Messrs. Agier, Petoton 
and Rougier, reviews and approves employment policies and administers the 
1992 Stock Incentive Plan.  The Compensation Committee held one (1) 
meeting during Fiscal 1996.

  A vote of a plurality of all shares of the common stock present in 
person or by proxy and voting at the Annual Meeting is necessary for the 
election of the nominees as directors of the Corporation.  IF LIMAGRAIN, 
WHICH CONTROLS APPROXIMATELY 85% OF THE ISSUED AND OUTSTANDING SHARES OF 
COMMON STOCK OF THE CORPORATION, VOTES ITS SHARES IN FAVOR OF THE 
ELECTION OF THE NOMINEES FOR THE BOARD OF DIRECTORS NAMED ABOVE, THEN 
SUCH NOMINEES WILL BE ELECTED TO THE BOARD OF DIRECTORS, REGARDLESS OF 
THE VOTE OF ANY OTHER SHAREHOLDER.

THE BOARD OF DIRECTORS RECOMMENDS ELECTION OF THE NOMINEES LISTED ABOVE 
AS DIRECTORS OF THE CORPORATION.


       PROPOSAL 2.  RATIFICATION OF APPOINTMENT OF
                 INDEPENDENT AUDITORS

   The Board of Directors has selected KPMG Peat Marwick LLP, independent 
auditors, to audit the financial statements of the Corporation for the 
fiscal year ending June 30, 1997.  KPMG Peat Marwick LLP has audited the 
Corporation's financial statements annually since 1981.

   Representatives of KPMG Peat Marwick LLP will be available for the 
Annual Meeting with the opportunity to make a statement and to respond to 
appropriate questions.

   A vote of the majority of all shares present in person or by proxy and 
voting at the Annual Meeting is necessary for the ratification of KPMG 
Peat Marwick LLP as the Corporation's independent auditors for the fiscal 
year ending June 30, 1997. If the appointment of KPMG Peat Marwick LLP is 
not approved at the Annual Meeting, the Board of Directors will consider 
the selection of another accounting firm.  IF LIMAGRAIN, WHICH CONTROLS 
APPROXIMATELY 85% OF THE ISSUED AND OUTSTANDING SHARES OF COMMON STOCK OF 
THE CORPORATION, VOTES ITS SHARES IN FAVOR OF THE RATIFICATION OF THE 
APPOINTMENT OF KPMG PEAT MARWICK LLP AS THE CORPORATION'S INDEPENDENT 
AUDITORS FOR THE FISCAL YEAR ENDING JUNE 30, 1997, THE APPOINTMENT WILL 
BE RATIFIED REGARDLESS OF THE VOTE OF ANY OTHER SHAREHOLDER.

   THE BOARD OF DIRECTORS RECOMMENDS THE RATIFICATION OF THE APPOINTMENT 
OF KPMG PEAT MARWICK LLP AS THE CORPORATION'S AUDITORS FOR THE FISCAL 
YEAR ENDING JUNE 30, 1997.

             SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS

   The following table sets forth certain information concerning the 
record and beneficial ownership of each shareholder known to the 
Corporation to be the beneficial owner of more than five percent of the 
Corporation's common stock as of September 20, 1996.  The persons 
identified have sole voting and investment power with respect to all such 
shares unless otherwise noted.

                       Number of Shares of     Approximate Percentage
                           Common Stock             of Common Stock
                       Beneficially Owned(1)      Beneficially Owned(2)
Groupe Limagrain              98,277,178(3)               85.2%
  Holding S.A.
BP1
63720 Chappes
France


                        Number of Shares of    Approximate Percentage   
                           Common Stock            of Common Stock
                        Beneficially Owned(1)     Beneficially Owned(2)

State Farm Automobile         11,324,051                   9.8%   
  Insurance Company
One State Farm Plaza
Bloomington, IL  61701

(1)    None of the shares disclosed in this column represent shares with 
     respect to which the holders thereof have the right to acquire bene-
     ficial ownership as specified in Rule 13d-3(d)(1) under the Securi-   
     ties Exchange Act of 1934, as amended.

(2)  Percentages of common stock held are based on 115,379,628 shares of
     common stock outstanding as of September 20, 1996.

(3)  Includes 98,277,178 shares of common stock owned beneficially and of
     record by its subsidiary LG Corp.


                MANAGEMENT OF BIOTECHNICA

SECURITY OWNERSHIP OF MANAGEMENT

   The following table sets forth, as of September 20, 1996, certain 
information regarding the beneficial ownership of the common stock held 
by each director, each nominee for election as a director and by all 
directors and executive officers as a group.  None of the directors 
beneficially own any other class of equity securities other than common 
stock.  The persons identified have sole voting and investment power with 
respect to such shares unless otherwise noted.  Claude Agier, Jean 
Ferrand, Laurent Petoton, Emmanuel Rougier, Bruno Carette, George 
Allbritten and Philip Nordeen are not the record or beneficial owners of 
any shares of common stock.

                          Number of Shares of     Approximate Percentage
                          Common Stock            of Common Stock
                          Beneficially Owned      Beneficially Owned

Ralph W.F. Hardy		           	  4,830                     *

William C. Hittinger            4,000                     *

All directors and executive    20,080                     *
officers as a group--twelve
(12) persons

*Denotes less than 1%







INFORMATION ABOUT EXECUTIVE OFFICERS

   Information about the executive officers of the Corporation who are 
not nominees for election as Directors is set forth below.  All executive 
officers serve at the discretion of the Board of Directors.

                         Position with the Corporation, Principal
Name               Age   Occupations During the Last Five Years


Bruno Carette*      41   Mr. Carette was appointed President and Chief
                         Operating Officer of the Corporation as of 
                         July 1, 1996.  Prior to that date, he served as
                         Vice President, Sales and Marketing, since
                         August 22, 1994.  From 1990 to 1993, Mr. Carette
                         was Company Production Manager at Vilmorin S.A.,
                         a Limagrain affiliate.  Prior to that, he was 
                         the Overseas Production Manager from 1988 to 
                         1990.

Larry D. Rieffel*   49   Mr. Rieffel was appointed Vice President,
                         Production and Logistics as of July 1, 1996.      
                         Prior to that date he served as Corporate 
                         Production and Logistics Manager of the 
                         Corporation since July 1, 1994.  Prior to that, 
                         he served in various senior management positions 
                         of the Corporation and with NobleBear Seed 
                         Company before it was acquired by the 
                         Corporation.

Edward M. Germain*  44   Mr. Germain was appointed Vice President,
                         Finance, Chief Financial Officer and Secretary 
                         of the Corporation as of July 1, 1996.  Prior
                         to that date, he served as Chief Financial
                         Officer and Secretary of the Corporation since
                         November 1, 1994.  Prior to that, he served as  
                         Controller of Shissler Seed Company from 1993 
                         to 1994 and held various financial and 
                         management positions with Briggs Industries,
                         Inc. and Pekin Energy Company.

Roger Bonsack*      43   Mr. Bonsack was appointed National Sales Manager
                         of the Corporation as of July 1, 1996.  Prior to
                         that date, he was the Location Sales and
                         Marketing Manager of the Corporation's Tekamah,
                         NE Service Center since July, 1991.  Prior to 
                         that, he served in various management positions
                         with Dekalb Genetics.

Jacqui Doublier*    45   Mr. Doublier was appointed Manager, Marketing 
                         and Product Development of the Corporation as of
                         September 16, 1996.  Prior to that, he was 
                         Export Sales Manager from 1989 to 1996 at
                         Vilmorin S.A., a Limagrain affiliate in the 
                         field of vegetable seeds.

Philip M. Nordeen   36   Mr. Nordeen was appointed Chief Accounting
                         Officer and Treasurer of the Corporation as of
                         November 1, 1994.  Prior to that date, Mr. 
                         Nordeen served in various financial management 
                         positions in the former BioTechnica organization 
                         and with Commerce Bank of Kansas City.

*Indicates a member of the BioTechnica International, Inc./LG Seeds, Inc.  
 Operating Committee. 


        REPORT OF THE COMPENSATION COMMITTEE OF THE 
        BOARD OF DIRECTORS ON EXECUTIVE COMPENSATION

   The following is the report of the Compensation Committee of the 
Corporation (the "Committee") on executive compensation for Fiscal 1996 
for executives of the Corporation other than the CEO.

   COMPENSATION PHILOSOPHY:  The Committee believes that it is in the 
best interest of the shareholders of the Corporation for the Corporation 
to attract, maintain and motivate top quality management personnel, 
especially its executive officers.  The general philosophy of the 
Committee is to integrate (i) reasonable levels of annual base 
compensation and (ii) annual cash bonuses based on achievement of short-
term corporate and individual performance goals, such that executive 
compensation levels will be higher in years in which performance goals 
are achieved or exceeded.

   The elements of the Committee's integrated compensation philosophy are 
summarized as follows:

   BASE COMPENSATION LEVELS:  The base compensation levels for the 
management of the Corporation are determined according to the 
compensation policy in place at Limagrain for its executives.

   PERFORMANCE BASED COMPENSATION:  The compensation package for 
management of the Corporation also includes performance-based elements.  
Annual cash bonuses can be earned based on achievement of Corporation 
and/or individual base performance goals determined at the beginning of 
the year by the Chairman of the Committee for Mr. Carette, President and 
Chief Operating Officer of the Corporation, and proposed by Mr. Carette 
and reviewed by the Chairman of the Committee for all other executives.  
Economic results are the primary measure of Corporate performance.

   RELATIONSHIP OF CORPORATE PERFORMANCE TO FISCAL 1996 COMPENSATION: 
Jean-Christophe Gouache was President and Chief Operating Officer of the 
Corporation from March 1994 until June 30, 1996, at which time he 
resigned to accept the position of General Manager of Dolisos-France, a 
Limagrain affiliate in France.  For Fiscal 1996, the performance based 
compensation amount for Mr. Gouache consisted of a cash bonus to be paid 
subsequent to the end of the fiscal year.  The amount to be paid will be 
calculated based on four factors:  (i) an amount based on an increase in 
sales; (ii) an amount equal to 0.3% times an amount approximately equal 
to cash generated by operations; (iii) an amount based upon the 
attainment of specific action goals as determined by the CEO; and (iv) an 
amount based upon the financial results of Limagrain Genetics Inter-
national.  Based on these criteria, no performance-based compensation was 
paid to Mr. Gouache for Fiscal 1996.

  A substantially similar arrangement existed for Fiscal 1995 under which 
Mr. Gouache received a cash bonus of $3,161.  The compensation arrange-
ment for Mr. Carette for Fiscal 1997 will be substantially similar to 
that of Mr. Gouache.

   COMPENSATION OF CHIEF EXECUTIVE OFFICER:  Mr. Rougier, the Chief 
Executive Officer of the Corporation, does not receive any compensation 
directly from the Corporation.  Mr. Rougier is an employee of Limagrain, 
not the Corporation.  The Corporation has entered into a service 
agreement (see "CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS") with 
Limagrain Genetics International, an affiliate of the Corporation, to 
provide various management, administrative, and financial services.  This 
service agreement covers services provided by Mr. Rougier and, therefore, 
the cost of Mr. Rougier's services are covered by and included in the 
service agreement.  The Corporation does not provide any additional 
direct or indirect compensation to Mr. Rougier.

   The Compensation Committee is composed of Mr. Rougier, CEO of the 
Corporation, and Messrs. Petoton and Agier, neither of whom are employees 
of the Corporation, but both of whom are members of the Board of 
Directors of Limagrain.
                                        Emmanuel Rougier, Chairman
                                        Laurent Petoton
                                        Claude Agier



                     STOCK PERFORMANCE GRAPH

   The following line graph compares the yearly percentage change:

     (i)  in the Corporation's cumulative Total Stockholders Return (as
          herein defined) (the solid line); with

    (ii)  the cumulative Total Stockholders Return of the NASDAQ
          United States Composite Index (the long broken line); with

   (iii)  the cumulative Total Stockholders Return of a customized group
          of companies involved in the seed industry (the "Custom
          Composite Index") (the short broken line).

   "Total Stockholders Return" is calculated quarterly, with dividends 
reinvested at the ex-dividend date for each quarter and return 
compounded.  The graph uses an initial investment of $100 on December 31, 
1990, cumulating the total return for each month for each component, 
BioTechnica, the NASDAQ United States Composite Index and the Custom 
Composite Index, each assuming dividend reinvestment.  The Custom 
Composite Index was prepared by weighting the return of each group member 
according to its respective market capitalization on a quarterly basis.

   The Custom Composite Index consists of AgriBioTech, Inc., Calgene 
Inc., DEKALB Genetics Corp. - Class B, Delta and Pine Land Co., Mycogen 
Corp., Pioneer Hi-Bred International, The Scotts Company - Class A, and 
Zeneca Group Plc-ADR.  Some companies included in the Custom Composite 
Index became publicly traded after December 1989.  These companies and 
the dates they began trading are:  The Scotts Company-Class A-January 31, 
1992; Zeneca Group Plc ADR-May 12, 1993; Delta and Pine Land Co.-June 30, 
1993; and AgriBioTech, Inc.-December 13, 1993.

   The Corporation's fiscal year currently ends June 30.  Prior to 1994, 
the Corporation's fiscal year ended July 31; prior to 1992, the 
Corporation's fiscal year ended December 31.
 
   The historical stock price performance shown on this graph is not 
necessarily indicative of future performance. 

<TABLE>

                   12/91    7/92     7/93     6/94     6/95     6/96
<CAPTION>
<S>                <C>    <C>      <C>      <C>      <C>      <C>
BioTechnica Intl.  $100   $126.32  $ 94.74  $ 19.74  $ 10.53  $ 31.58
Custom Composite   $100   $149.17  $159.34  $182.37  $239.10  $321.63
  Index
NASDAQ Market 
  Index            $100   $107.74  $132.27  $145.04  $170.11  $214.14

</TABLE>

                    EXECUTIVE COMPENSATION

   SUMMARY COMPENSATION TABLE:  The following table summarizes, for each 
of the last three fiscal periods, the compensation awarded, paid to or 
earned by (i) the CEO of the Corporation, (ii) the COO, who performs many 
of the functions normally associated with the CEO function, and (iii) 
each of the four most highly compensated executive officers other than 
the CEO who served as executive officers of the Corporation or its 
subsidiaries, as of June 30, 1996, whose annual compensation exceeded 
$100,000, if any.  The Corporation does not currently award restricted 
stock, stock options, stock appreciation rights, or other long-term 
incentive compensation under its executive compensation program.

<TABLE>

                    SUMMARY COMPENSATION TABLE  

                                           Long-Term
                                          Compensation
    Name and         Annual Compensation     Awards      All Other
Principal Position    Year    Salary    Bonus  Options/SARs   
Compensation
<CAPTION>
<S>                   <C>  <C>           <C>       <C>
Emmanuel Rougier                (1)
Chief Executive Officer

Jean-Christophe (J.C.) 
  Gouache             1996 $122,132(2)   $ -0-     (3)
President and Chief   1995  107,330(2)   $3,161    (3)
  Operating Officer   1994   73,200(2)   13,255    (3) 


No other officers of the Corporation had annual compensation in excess of 
$100,000.


(1)  Mr. Rougier is not paid by the Corporation.  See "COMPENSATION OF 
     CHIEF EXECUTIVE OFFICER" and "CERTAIN RELATIONSHIPS AND RELATED 
     TRANSACTIONS."
(2)  Includes personal use of Corporation automobile.
(3)  Mr. Gouache was covered under the retirement system established
     under French law.  The French retirement system is similar to the
     United States social security system -- a company makes mandatory
     contributions on behalf of all of its employees based on a
     percentage of the employee's salary.  The funds are paid to, and
     administered by, a governmental entity.  The amount of the
     contribution on behalf of each employee is mandatory.  In addition,
     in France a company may elect to make additional contributions
     on behalf of its employees and if a company chooses to do so,
     such additional contributions are governed by the same principles
     as for the mandatory contributions as described herein.  Limagrain
     normally makes additional contributions on behalf of all of its
     employees.  See discussion of Limagrain Genetics International 
     Service Agreement under "CERTAIN RELATIONSHIPS AND OTHER RELATED
     TRANSACTIONS."
     
</TABLE>

              OPTION/SAR GRANTS IN FISCAL 1996

   During Fiscal 1996, there were no options/SARs granted to any 
director, officer or employee of the Corporation.

 
     AGGREGATE OPTION/SAR EXERCISES IN FISCAL 1996
          AND OPTION VALUES AT JUNE 30, 1996

  During Fiscal 1996, there were no options/SARs exercised by any 
officer, director or employee of the Corporation and there were no 
unexercised in-the-money options/SARs outstanding to any officer, 
director or employee as of June 30, 1996.





                    STOCK OPTION REPURCHASES

   During Fiscal 1996, the Corporation repurchased 70,000 stock options 
from certain directors and executive officers for an aggregate purchase 
price of $3,400 (i.e., for an average purchase price of 4.9 cents per 
underlying share).  The repurchase of the options, which had exercise 
prices of between $1.31 and $3.50 per share, resulted in a reduction of 
approximately $66,000 in long-term liabilities.


         COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION

   None of the members of the Compensation Committee has ever been (i) an 
employee or officer of the Corporation or any of its subsidiaries or (ii) 
had any relationship requiring disclosure under any paragraph of Item 404 
or in Item 402(j)(3) of Regulation S-K promulgated by the Commission, 
with the exception of Mr. Rougier, who has served as the CEO of the 
Corporation since March 1994.  Mr. Rougier does not receive compensation 
directly from the Corporation.  Mr. Rougier is an employee of Limagrain, 
not the Corporation.  The Corporation has entered into a service 
agreement (see "CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS") with 
Limagrain Genetics International, an affiliate of the Corporation, to 
provide various management, administrative, and financial services.  This 
service agreement covers services provided by Mr. Rougier and, therefore, 
the cost of Mr. Rougier's services are covered by and included in the 
service agreement.  The Corporation does not provide any additional 
direct or indirect compensation to Mr. Rougier.  Messrs. Agier and 
Petoton are representatives of Limagrain.


  CERTAIN RELATIONSHIPS AND OTHER RELATED TRANSACTIONS

   The Corporation, through relationships with LG Corp. (its 85% parent), 
is an affiliate of Limagrain.  The Limagrain Group ("Limagrain Group") 
consists of a cooperative of approximately 500 French farmers and the 
multi-national group of companies owned by them.  In total, these 
companies represent the third largest seed company in the world.  The 
Limagrain Group is recognized as a leader in seed research, seed 
production, and seed marketing, as well as biotechnology research and 
applications.  The Limagrain Group also has investments and joint 
ventures with other companies throughout the world in various 
agribusiness industries.

   The Corporation has contractual relationships with a number of other 
Limagrain affiliated companies.  The terms of these contracts are 
negotiated annually between the Corporation and each individual 
affiliated company.  Management believes that such contracts (i) are 
reasonable, necessary and in the best interests of all of the 
shareholders of the Corporation, and (ii) are on terms no less favorable 
to the Corporation than the Corporation could obtain from non-affiliated 
third parties or on which the Corporation could internally perform the 
services provided in such contracts.  The Audit Committee of the Board of 
Directors of the Corporation has independently reviewed the basis for 
these contracts and has recommended that the Board of Directors of the 
Corporation approve and ratify such contracts as are in effect for the 
current fiscal year.  The Board of Directors of the Corporation, 
including all of the Directors unaffiliated with Limagrain, has 
unanimously voted to approve and ratify such contracts as are in effect 
for the current fiscal year.  

   A summary of significant relationships follows below:

EXPORT HYBRID CORN SALES TO AFFILIATED COMPANIES

   The Corporation produces and sells seed corn grown in the United 
States to affiliates of Limagrain in Europe. These agreements are 
renegotiated each year, based on product conditions at the time, 
availability of extra capacity at the Corporation's production and 
processing facilities, and the needs of the European affiliates of 
Limagrain.  Such negotiations are conducted on an arms-length basis by 
management of the Corporation and a representative of the respective 
affiliate.  These agreements specifically identify the product to be 
produced by the Corporation, the quantity to be purchased, and the 
quality and specifications for that product.  Management believes that 
these contracts are a benefit to the Corporation in that they cover the 
variable costs involved, contribute to absorbing fixed operating costs 
and augment the profits of the Corporation.  There is no assurance that 
the Corporation and the Limagrain affiliates will continue to reach 
agreement on such arrangements in the future and, in such event, there 
will be a negative impact upon the Corporation's sales and profit 
margins.  During Fiscal 1996, the total sales made under these contracts 
amounted to $1,489,000.


HYBRID CORN LICENSE AGREEMENT

   The Corporation has entered into an agreement with LG Corp. to allow 
the Corporation to market various proprietary hybrid corn genetics 
developed through the LG Corp. research program.  In exchange for the 
right to sell these proprietary genetics, the Corporation has agreed to 
pay royalties to LG Corp.  For Fiscal 1996, the amount of these royalties 
was approximately $94,000.  Management anticipates that the royalty rate 
will remain stable but that the dollar amount paid to LG Corp. under this 
agreement will increase in the future due to an increase in the volume of 
sales of these genetics.

   Management believes the royalties paid under this agreement are as or 
more favorable to the Corporation as compared to the royalties paid in 
the seed corn industry generally for the use of proprietary genetic 
material.

SOYBEAN GENETICS LICENSE AGREEMENT

   The Corporation has entered into an agreement with LG Corp. to allow 
the Corporation to market various proprietary soybean products developed 
through its soybean research program.  In exchange for the right to sell 
these products, the Corporation has agreed to pay royalties to LG Corp.  
For Fiscal 1996, the amount of these royalties was approximately $50,000. 
LG Corp. makes the same type of products available to non-affiliated 
competitor companies in the seed industry.  Management believes the 
royalty rates charged to the Corporation are as favorable to the 
Corporation as compared to the royalty rates charged to non-affiliated 
customers of LG Corp.




BIOTECHNOLOGY SERVICE AGREEMENT

   The Corporation has entered into an agreement with BIOCEM S.A. 
("BIOCEM") (an affiliate of Limagrain) to provide access to the 
biotechnology research conducted by the Limagrain Group around the world.  
Through this agreement, the Corporation not only has access to the 
results of the research but also has the right to propose topics for 
future study.

   During Fiscal 1996, the Corporation paid $30,000 to BIOCEM under the 
terms of this agreement.  Management believes that the fees paid pursuant 
to this agreement are as or more favorable to the Corporation as compared 
to (i) the fees that the Corporation would have to pay to a non-
affiliated party for substantially similar services and (ii) the costs 
required to perform such services internally.

LIMAGRAIN INNOVATIONS SERVICE AGREEMENT

   The Corporation has entered into an agreement with Limagrain 
Innovations (an affiliate of Limagrain) whereby Limagrain Innovations 
will provide various administrative, financial and accounting services to 
the Corporation that the Corporation does not otherwise provide for 
itself.  Limagrain Innovations is the worldwide "corporate" function of 
the Limagrain Group.  Significant items covered under this agreement are:

     a.  STRATEGIC PLANNING AND CONTROL
         Limagrain Innovations monitors the economic environment of the
         Corporation, and the seed industry in general, and provides
         advice and guidance to management in developing long-term
         plans and objectives.  In addition, Limagrain Innovations
         assists in the preparation and review of the annual long-
         term planning documents of the Corporation.

     b.  HUMAN RESOURCES AND BENEFITS
         Limagrain Innovations provides assistance to the Corporation
         in the form of recruitment services, career evaluation, 
         training opportunities, and compensation evaluation.  In
         addition, Limagrain Innovations coordinates and evaluates
         the benefit programs offered by the Limagrain Group companies
         in North America.

     c.  FINANCING/TREASURY ACTIVITIES
         Limagrain Innovations provides technical support for the
         Corporation in negotiations with its bankers.  In addition,
         Limagrain Innovations provides short-term financing to the
         Corporation to meet cash flow requirements.  Limagrain
         Innovations has been critical in negotiating favorable
         interest rates and financing terms.

     d.  AUDITING SERVICES
         Limagrain Innovations assists the Corporation in negotiations
         with its outside auditors regarding the cost of services.
         Limagrain Innovations also provides internal audit services to
         the Corporation.

   The Corporation paid $90,000 to Limagrain Innovations under this 
service agreement for Fiscal 1996. Management believes that the fees paid 
pursuant to this agreement are as or more favorable to the Corporation as 
compared to (i) the fees that the Corporation would have to pay to a non-
affiliated party for substantially similar services and (ii) the costs 
required to perform such services internally.

LIMAGRAIN GENETICS INTERNATIONAL SERVICE AGREEMENT

   The Corporation has entered into an agreement with Limagrain Genetics 
International ("LGI") (an affiliate of Limagrain) whereby LGI will 
provide various administrative, technical and marketing services to the 
Corporation.  LGI is the "division" of the Limagrain Group responsible 
for the operations of the Corporation.

     a.  CHIEF EXECUTIVE OFFICER
         LGI provides the services of the Chief Executive Officer
         of the Corporation, Mr. Emmanuel Rougier.  In addition,
         LGI pays all travel and other expenses for Mr. Rougier in
         his capacity as Chief Executive Officer of the Corporation.

     b.  BOARD OF DIRECTORS
         In their capacity as Board members of LGI, four directors of
         LGI are representatives of Limagrain on the Board of Directors
         of the Corporation.  No fees or costs are paid by the
         Corporation for the services of these directors.

     c.  RESEARCH
         LGI coordinates the traditional plant breeding programs of
         the Limagrain Group for the crops the corporation markets.
         The Corporation receives information on the results of
         these activities and has the opportunity to provide
         suggestions on potential avenues of future research.

     d.  MARKETING PLANNING
         LGI provides advice and planning services to the Corporation
         in regard to the development of business and marketing plans
         and strategies.

     e.  ADMINISTRATIVE/ACCOUNTING SUPPORT
         LGI provides expertise to the Corporation in monitoring
         short-term planning and month-to-month financial analysis
         and control.

     f.  BRAND NAME
         LGI allows the Corporation to use the "LG" brand name and
         logo in its marketing efforts.

   The Corporation paid $200,000 to LGI under this service agreement for 
Fiscal 1996. Management believes that the fees paid pursuant to this 
agreement are as or more favorable to the Corporation as compared to (i) 
the fees that the Corporation would have to pay to a non-affiliated party 
for substantially similar services and (ii) the costs required to perform 
such services internally.

   LGI pays retirement and certain other benefits provided for under 
French law on behalf of French citizens employed by the Corporation.  The 
Corporation reimburses these benefit costs to LGI.  For Fiscal 1996, 
these costs amounted to $74,000 and provided benefits for two employees 
of the Corporation.



NICKERSON SA SERVICE AGREEMENT

   The Corporation has entered into an agreement with Nickerson SA 
("Nickerson") (an affiliate of Limagrain) whereby the Corporation will 
provide office space and one employee to Nickerson for use in monitoring 
its business in the United States.  The agreement also calls for the 
Corporation to pay invoices on behalf of Nickerson, which Nickerson 
reimburses to the Corporation on a monthly basis.

   Under the terms of this agreement, in addition to the reimbursement of 
direct expenses as described above, Nickerson was invoiced $49,000, plus 
start-up costs, by the Corporation for Fiscal 1996.

FINANCIAL TRANSACTIONS WITH AFFILIATES

   At June 30, 1996, LG Corp. had one outstanding loan to the Corporation 
- -- a two-year note in the amount of $3,260,846.  The note is subordinated 
to all debt outstanding to Harris Bank and Trust Company.  The note bears 
interest at LIBOR (London Inter-bank Offered Rate) plus 0.4375% and is 
due July 1, 1998. In addition, from time to time during Fiscal 1996, the 
Corporation was advanced cash by LG Corp. and other Limagrain affiliates, 
to allow the Corporation to meet covenants under the revolving credit 
arrangement with its bank.  The Corporation reimbursed LG Corp. and other 
Limagrain affiliates for actual interest costs and fees incurred to 
borrow these funds.  Except as described below, all of these advances 
have been repaid to LG Corp. and other Limagrain affiliates as of June 
30, 1996.

   At June 30, 1996, Ferry-Morse Seed Company, an affiliate of Limagrain 
headquartered in Modesto, CA, made a short-term cash advance to the 
Corporation in the amount of $2,000,000.  This advance bore interest at 
the rate of LIBOR plus 0.50% and was paid in full on August 30, 1996.

   Management believes these loans bear interest at or below a rate which 
the Corporation would be able to obtain from an unaffiliated lender for 
an unsecured loan.

   On November 30, 1995, the Corporation issued to LG Corp. 200,000 
shares of the Corporation's Class A Preferred Stock at $10.00 per share, 
in exchange for the surrender of a promissory note evidencing $2,000,000 
in long-term debt.  LG Corp. currently owns $9,000,000 (900,000 shares) 
of Class A Preferred Stock of the Corporation.  

  There is no assurance that LG Corp., or any other affiliate of 
Limagrain, will continue to (i) guarantee the Corporation's credit 
arrangement (which it has not had the legal obligation to do since 
November 1994), (ii)loan funds to the Corporation, or (iii) invest 
additional equity in the Corporation.  In addition, there is no assurance 
that, without such guarantees, loans, and/or investments, the Corporation 
would not be out of compliance with (a) the terms of its bank line of 
credit, or (b) the NASDAQ Stock Market quantitative maintenance criteria, 
during seasonal fluctuations in the Corporation's borrowing base and net 
tangible assets, respectively.

   On July 31, 1996, the Corporation received a long-term cash advance of 
$1,000,000 from an affiliate in order to help fund operations of the 
Corporation.  On August 30, 1996, this long-term cash advance was re-
negotiated and increased to a $2,000,000 note with LG Corp. bearing 
interest of 7% and due July 1, 1998.


TAX SHARING AGREEMENT

  The Corporation, LG Corp., and each of LG Corp.'s other subsidiaries 
entered into a Tax Sharing Agreement as of November 30, 1994.  The 
purpose of this Tax Sharing Agreement is to provide for an annual system 
of allocating federal tax liabilities and certain state and local tax 
liabilities of LG Corp., the Corporation, and each of LG Corp.'s other 
subsidiaries for purposes of computing each member's annual earnings and 
profits and making cash payments between the members to reflect the 
allocation of such tax liabilities.  Generally, the parties to the Tax 
Sharing Agreement have agreed to allocate their consolidated income tax 
liabilities in accordance with the method provided in Section 1552(a)(1) 
of the Internal Revenue Code, as amended, and the regulations promulgated 
thereunder.



                    OTHER MATTERS

   The Board of Directors knows of no other business which will be 
presented at the Annual Meeting.  If any other business is properly 
brought before the Annual Meeting, it is intended that the shares 
represented by the enclosed proxy will be voted in respect thereof in 
accordance with the judgment of the persons voting the proxies.    


         DEADLINE FOR RECEIPT OF SHAREHOLDERS' PROPOSALS

   Proposals of shareholders of the Corporation which are intended to be 
presented by the Corporation at the Corporation's 1997 annual meeting of 
shareholders must be received by the Corporation no later than June 12, 
1997, that they may be included in the Proxy Statement and Form of Proxy 
relating to that meeting.

GENERAL

   In order that your shares may be represented if you do not plan to 
attend the meeting, and in order to assure the required quorum, please 
sign, date and return your proxy promptly.

               INCORPORATION BY REFERENCE

   The following information from the Corporation's Annual Report to 
Shareholders for the fiscal year ended June 30, 1996, and which 
accompanies this Proxy Statement is incorporated herein by reference: 
"Business," "Properties," "Market for the Registrant's Common Equity and 
Related Stockholder Matters," and "Management's Discussion and Analysis 
of Financial Condition and Results of Operations."

                                 By Order of the Board of Directors


                                 /s/ Bruno Carette
October 10, 1996                 President and Chief Operating Officer



Appendix I: Proxy Card
                        BIOTECHNICA INTERNATIONAL, INC.

      THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS FOR THE 
ANNUAL MEETING OF THE SHAREHOLDERS TO BE HELD ON NOVEMBER 12, 1996

The undersigned hereby appoints Bruno Carette and Edward M. Germain,
and each of them, with power of substitution in each, the proxy (the 
"Proxy") for and in the name of the undersigned to vote all shares of 
Common Stock, $.01 par value, of BioTechnica International, Inc. (the 
"Corporation") which the undersigned should be entitled to vote at the 
Annual Meeting of Shareholders of the Corporation to be held on November 
14, 1995, and at any adjournments thereof, upon matters set forth in the 
Notice of Meeting, as indicated on the reverse side of this proxy card.

          (Continued and to be voted, signed and dated on reverse side)
         
      Please mark your
  X   votes as in this
      example



     For all nominees             Withheld Authority
     listed at right (except to   to vote for all
     vote as marked to the        nominees
     contrary below)              listed at right
                                       
                                   Nominees:Claude Agier
  1. Election                               George Allbritten
     of                                     Jean Ferrand 
     Directors                              Ralph W.F. Hardy
                                            William C. Hittinger
Instructions: To withhold authority to vote  Laurent Petoton
for any nominee write that nominee's name   Emmanual Rougier
in the space provided below

                                              FOR     AGAINST    ABSTAIN 

  2. Approval of the appointment of KPMG
     Peat Marwick LLP, independent certified
     public accountants, as auditors for the
     Corporation for the fiscal year ending
     June 30, 1997.

  3. In their discretion, the Proxies are further authorized to vote upon 
such other business as may properly come before this meeting

  THE PROXY WHEN PROPERLY EXECUTED WILL BE VOTED IN THE MANNER DIRECTED
  HEREIN BY THE UNDERSIGNED SHAREHOLDER, IF NO DIRECTION IS MADE, 
THIS 
  PROXY WILL BE VOTED FOR THE ELECTION OF ALL NOMINEES AND FOR PROPOSAL 
  2.

  Note: These matters have been proposed by the Corporation and are not
        related to or conditioned on the approval of other matters.


Signature __________ Date _________  Signature __________  Date ________

  Note: Where stock is registered jointly in the name of two or more 
persons, all should sign. Signature(s) should correspond exactly with the 
names as shown above. Please sign and date and return promptly in the 
enclosed envelope. No postage need be affixed if mailed in the United 
States.




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission